Table 4 Cancer characteristics for supplemental and primary US screening for breast cancer
From: Performance of ultrasonography screening for breast cancer: a systematic review and meta-analysis
Author, year | Method | Proportions of invasive cancers, % | Proportions of node-negative invasive cancers, % | ||
|---|---|---|---|---|---|
Number | 95% CI | Number | 95% CI | ||
Supplemental US screening studies | |||||
 Tagliafico, 2016 [21] | Supplemental US | 22/23 | 95.7(76.0–99.8) | 13/20 | 65.0(40.9–83.7) |
 Kim, 2016 [22] | Supplemental US | 7/9 | 77.8(40.2–96.1) |  |  |
 Weigert, 2015 [26] | Supplemental US | 10/22 | 45.5(25.1–67.3) |  |  |
 Hwang, 2015 [25] | Supplemental US | 7/8 | 87.5(46.7–99.3) |  |  |
 Moon, 2015 [24] | Supplemental US | 2/4 | 50.0(15.0–85.0) | 1/2 | 50.0(9.5–90.5) |
 Leong, 2012 [32] | Supplemental US | 1/2 | 50.0(9.5–90.5) |  |  |
 Hooley, 2012 [31] | Supplemental US | 2/3 | 66.7(12.5–98.2) | 2/2 | 100.0(19.8–100.0) |
Joint screening studies | |||||
 Dong, 2017 [9] | Primary MAM | 30/63 | 47.6(35.0–60.5) | 16/30 | 53.3(34.6–71.2) |
Primary US | 25/46 | 54.3(39.2–68.8) | 13/25 | 52.0(31.8–71.7) | |
 Ohuchi, 2016 [10] | Primary MAM | 73/117 | 62.4(52.9–71.0) | 54/73 | 74.0(62.2–83.2) |
Primary US | 111/143 | 77.6(69.7–84.0) | 89/111 | 79.3(70.3–86.2) | |
 Berg, 2016 [11] | Primary MAM | 41/59 | 69.5(56.0–80.5) |  |  |
Primary US | 53/58 | 91.4(80.3–96.8) |  |  | |
 Brem, 2015 [39] | Primary MAM | 51/82 | 62.2(50.8–72.5) | 46/48 | 95.8(84.6–99.3) |
Primary US | 73/95 | 76.8(66.8–84.6) | 65/69 | 94.2(85.1–98.1) | |
 Huang, 2012 [30] | Primary MAM | 24/28 | 85.7(66.4–95.3) |  |  |
Primary US | 22/23 | 95.7(76.0–99.8) |  |  | |
 Kelly, 2010 [40] | Primary MAM | 17/23 | 73.9(51.3–88.9) |  |  |
Primary US | 35/38 | 92.1(77.5–97.9) |  |  | |
 Wilczek, 2016 [38] | Primary MAM | 5/7 | 71.4(30.3–94.9) |  |  |
Primary US | 9/11 | 81.8(47.8–96.8) |  |  | |
 Venturini, 2013 [29] | Primary MAM | 8/12 | 66.7(35.4–88.7) |  |  |
Primary US | 2/2 | 100.0(19.8–100.0) |  |  | |
 Weinstein, 2009 [35] | Primary MAM | 3/7 | 42.9(11.8–79.8) | 3/3 | 100.0(31.0–100.0) |
Primary US | 3/3 | 100.0(31.0–100.0) | 3/3 | 100.0(31.0–100.0) | |
 Honjo, 2007 [37] | Primary MAM | 5/8 | 62.5(25.9–89.8) | 4/5 | 80.0(29.9–98.9) |
Primary US | 7/7 | 100.0(56.1–100.0) | 6/7 | 85.7(42.0–99.2) | |